Muscle dysfunction as a systemic marker of risk for exacerbation of COPD patients: the Spanish "IMAGIM study" Source: Eur Respir J 2004; 24: Suppl. 48, 2s Year: 2004
A BTNL2 gene variant confers to sarcoidosis susceptibility by an increased risk towards the chronic form of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 148s Year: 2006
The genetic markers (HLA system) of steroid-resistance in severe bronchial asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006
Endothelin-1 polymorphism involved in the impaired exercise tolerance in COPD patients: A precursor of pulmonary hypertension? Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010
Polymorphisms of the beta adrenoceptor are associated with severity of disease, but not disease susceptibility, in subjects with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 378s Year: 2002
The role of smoking in development of endothelial dysfunction in patients with COPD in combination with AH Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011
Association of angiopoietin-like protein 4 with cardiovascular function in patients with COPD Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016
HLA-DRB1 allele frequencies in Finnish sarcoidosis patients and associations with disease prognosis Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010
Polymorphic variants of genes ADRB2, NR3C1, MDR1 in patients with chronic obstructive pulmonary disease and obesity Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015
Association of clusters of pulmonary function data with SNP polymorphisms in sarcoidosis patients Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008
Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013
Is the BTNL2 genotype associated with specific HLA-DRB1 and DRB3/4/5 alleles in Danish sarcoidosis patients? Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015
Ninety seven independent genomic signals for lung function predict susceptibility to moderate to severe COPD Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016
HLA class II alleles and haplotypes are associated to the presence autoantibodies and mortality in Hypersensitivity Pneumonitis patients. Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018
High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015
Lung cancer gene associated with COPD: triple whammy or possible confounding effect? Source: Eur Respir J 2008; 32: 1158-1164 Year: 2008
Prognostic risk factors of disease worsening in patients with functional class II pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012
ß2-adrenergic receptor polymorphisms and risk of COPD Source: International Congress 2018 – Role of omics in population studies Year: 2018
TNF promoter polymorphisms are associated with susceptibility and increased severity in secondary to tobacco and biomass smoke COPD in Mexican population Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015